<DOC>
	<DOC>NCT02432196</DOC>
	<brief_summary>This is a Prospective, Single Arm, Single Group Assignment, EU study to demonstrate the feasibility and safety of the Harpoon Medical TSD-5 in subjects with degenerative MR</brief_summary>
	<brief_title>Safety and Early Feasibility Study of the Harpoon Medical Device</brief_title>
	<detailed_description>Pairs of ePTFE suture will be placed in the posterior leaflet of the mitral valve using the Harpoon Medical TSD-5 in order to establish effective coaptation of the mitral leaflets</detailed_description>
	<mesh_term>Prolapse</mesh_term>
	<mesh_term>Mitral Valve Insufficiency</mesh_term>
	<mesh_term>Mitral Valve Prolapse</mesh_term>
	<criteria>Age &gt; 18 years All subjects referred for mitral valve surgery Presence of moderate to severe or severe mitral regurgitation as read on an echocardiographic study performed within 6 months prior to procedure. Able to sign informed consent Presence of isolated posterior leaflet mitral valve prolapse Subject is willing to return for followup and is capable of participating in all testing associated with this clinical investigation &lt; 18 years of age Infective endocarditis Severe Tricuspid regurgitation Anterior or bileaflet prolapse Functional mitral regurgitation Radiation or inflammatory (rheumatic) valve disease Requirement for concomitant cardiac surgery (e.g. coronary artery bypass grafting (CABG), aortic valve surgery, etc.) Cardiogenic shock at the time of enrollment ST segment elevation myocardial infarction requiring intervention within 7 days prior to enrollment Evidence of cirrhosis or hepatic synthetic failure Pregnancy at the time of enrollment Severe pulmonary hypertension (PA systolic pressure &gt; 60 mmHg) Previous cardiac surgery, or surgery on the left thoracic cavity or the cardiac apex Left ventricular, atrial or appendage thrombus Severely calcified mitral annulus Recent stroke (in the prior six months) STS risk score (for mitral valve repair) &gt; 6 percent Subjects with contraindications to transesophageal echocardiography Severe left ventricular dysfunction (EF &lt; 40 %) Excessively thin mitral leaflets Renal insufficiency (CKD stage 3 or above GFR &lt; 60)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Mitral Valve Repair</keyword>
	<keyword>Transapical</keyword>
	<keyword>artificial chordae</keyword>
</DOC>